Search Results | Journal of Experimental Medicine

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Four keys to unlock IgG

Falk Nimmerjahn, Jeffrey V. Ravetch

J Exp Med (2021) 218 (3): e20201753.

DOI: https://doi.org/10.1084/jem.20201753

Published: 16 February 2021

View article

Journal Articles

DC subset–specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo

Christian H.K. Lehmann, Anna Baranska, Gordon F. Heidkamp, Lukas Heger, Kirsten Neubert, Jennifer J. Lühr, Alana Hoffmann, Katharina C. Reimer, Christin Brückner, Simone Beck, Michaela Seeling, Melissa Kießling, Didier Soulat, Anne B. Krug, Jeffrey V. Ravetch, Jeanette H.W. Leusen, Falk Nimmerjahn, Diana Dudziak

J Exp Med (2017) 214 (5): 1509–1528.

DOI: https://doi.org/10.1084/jem.20160951

Published: 07 April 2017

View article

Includes: Supplementary data

Journal Articles

Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9–dependent innate immune activation

Kerstin Werninghaus, Anna Babiak, Olaf Groß, Christoph Hölscher, Harald Dietrich, Else Marie Agger, Jörg Mages, Attila Mocsai, Hanne Schoenen, Katrin Finger, Falk Nimmerjahn, Gordon D. Brown, Carsten Kirschning, Antje Heit, Peter Andersen, Hermann Wagner, Jürgen Ruland, Roland Lang

J Exp Med (2009) 206 (1): 89–97.

DOI: https://doi.org/10.1084/jem.20081445

Published: 12 January 2009

View article

Includes: Supplementary data

Journal Articles

The antiinflammatory activity of IgG: the intravenous IgG paradox

Falk Nimmerjahn, Jeffrey V. Ravetch

J Exp Med (2007) 204 (1): 11–15.

DOI: https://doi.org/10.1084/jem.20061788

Published: 16 January 2007

View article

Journal Articles

Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy

Yasuhito Hamaguchi, Yan Xiu, Kazuhiro Komura, Falk Nimmerjahn, Thomas F. Tedder

J Exp Med (2006) 203 (3): 743–753.

DOI: https://doi.org/10.1084/jem.20052283

Published: 06 March 2006

View article

Journal Articles

Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

Yoshikatsu Kaneko, Falk Nimmerjahn, Michael P. Madaio, Jeffrey V. Ravetch

J Exp Med (2006) 203 (3): 789–797.

DOI: https://doi.org/10.1084/jem.20051900

Published: 06 March 2006

View article

Includes: Supplementary data

NARROW

Four keys to unlock IgG

DC subset–specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo

Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9–dependent innate immune activation

The antiinflammatory activity of IgG: the intravenous IgG paradox

Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy

Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

Email alerts

Four keys to unlock IgG

DC subset–specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo

Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9–dependent innate immune activation

The antiinflammatory activity of IgG: the intravenous IgG paradox

Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy

Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

Email alerts

This Feature Is Available To Subscribers Only